Skip to main content
. 2020 Aug 7;73(11):e4047–e4057. doi: 10.1093/cid/ciaa1091

Table 3.

Clinical Characteristics by Ethnicity and Logistic Regression of Odds of Death

Characteristic White (n = 235) Black (n = 133) Asian (n = 94) Other (n = 17) Missing (n = 135) P Value
Male sex 146 (62.13) 76 (57.14) 60 (63.83) 12 (70.59) 88 (65.19) .63
Mean age, y (SD) 70.52 (15.69) 63.58 (19.08) 66.4 (15.88) 54.82 (15.25) 60.7 (18.11) <.01
Mean Elixhauser score (SD) 6.29 (7.25) 5.23 (6.85) 6.63 (7.15) 2.53 (4.37) 2.99 (5.12) <.01
Mean NEWS-2 score (SD) 5.09 (3.2) 4.93 (3.04) 4.74 (3.31) 5.41 (2.67) 5.39 (2.83) .28
Mean days to admission (SD) 6.99 (5.75) 7.33 (5.98) 6.15 (4.82) 7.29 (6.47) 8.16 (5.08) .49
Outcomes
 FiO2 ≥60% 100 (42.55) 61 (45.86) 43 (45.74) 5 (29.41) 70 (51.85) .31
 Admitted to ICU 23 (9.79) 20 (15.04) 15 (15.96) 2 (11.76) 27 (20.00) .10
 Received IVS 22 (9.36) 18 (13.53) 14 (14.89) 2 (11.76) 24 (17.78) .21
 Died in hospital 67 (28.51) 41 (30.83) 30 (31.91) 3 (17.65) 37 (27.41) .76
 Discharged alive 149 (63.40) 78 (58.65) 54 (57.45) 14 (82.35) 86 (63.70) .31
 Pending outcome 19 (8.09) 14 (10.53) 10 (10.64) 0 (0.00) 12 (8.89) .62
Comorbidities
 Any comorbidity 179 (76.17) 112 (84.21) 78 (82.98) 11 (64.71) 100 (74.07) .10
 Ischemic heart disease 33 (14.04) 16 (12.03) 18 (19.15) 0 (0.00) 13 (9.63) .12
 Chronic heart failure 19 (8.09) 11 (8.27) 1 (1.06) 0 (0.00) 6 (4.44) .07
 Hypertension 97 (41.28) 73 (54.89) 40 (42.55) 7 (41.18) 69 (51.11) .08
 Hyperlipidemia 57 (24.26) 32 (24.06) 27 (28.72) 2 (11.76) 33 (24.44) .66
 Diabetes 61 (25.96) 63 (47.37) 41 (43.62) 4 (23.53) 47 (34.81) <.01
 CKD 39 (16.60) 26 (19.55) 26 (27.66) 0 (0.00) 11 (8.15) <.01
 Peripheral vascular disease 11 (4.68) 3 (2.26) 0 (0.00) 0 (0.00) 4 (2.96) .19
 Stroke 28 (11.91) 13 (9.77) 11 (11.70) 1 (5.88) 4 (2.96) .05
 Atrial fibrillation 43 (18.30) 10 (7.52) 11 (11.70) 2 (11.76) 9 (6.67) <.01
 DVT/PE history 4 (1.70) 2 (1.50) 0 (0.00) 0 (0.00) 1 (0.74) .68
 Hemiplegia 6 (2.55) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) .04
 Dementia 42 (17.87) 9 (6.77) 10 (10.64) 0 (0.00) 9 (6.67) <.01
 Asthma 18 (7.66) 14 (10.53) 8 (8.51) 3 (17.65) 13 (9.63) .65
 COPD 22 (9.36) 3 (2.26) 3 (3.19) 0 (0.00) 2 (1.48) <.01
 Connective tissue disease 4 (1.70) 3 (2.26) 1 (1.06) 0 (0.00) 1 (0.74) .82
 Peptic ulcer 8 (3.40) 2 (1.50) 1 (1.06) 0 (0.00) 3 (2.22) .61
 Liver (noncirrhotic) 14 (5.96) 12 (9.02) 10 (10.64) 3 (17.65) 5 (3.70) .09
 Liver (cirrhotic) 2 (0.85) 4 (3.01) 6 (6.38) 0 (0.00) 1 (0.74) .02
 Solid tumor 33 (14.04) 9 (6.77) 8 (8.51) 1 (5.88) 8 (5.93) .06
 Hematologic tumor 4 (1.70) 1 (0.75) 1 (1.06) 0 (0.00) 2 (1.48) .92
 HIV/AIDS 1 (0.43) 7 (5.26) 1 (1.06) 0 (0.00) 0 (0.00) <.01
Logistic regression of odds of death by ethnicity
 Unadjusted, OR (95% CI) Intercept 1.17 (.73–1.88) 1.24 (.73–2.10) 0.48 (.13–1.71) 0.96 (.59–1.55)
 Adjusteda model, OR (95% CI) Intercept 1.85* (1.06–3.24) 1.78 (.97–3.29) 0.95 (.24–3.80) 1.63 (.93–2.84)

Data are presented as no. (%) unless otherwise indicated.

Abbreviations: CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DVT/PE, deep vein thrombosis/pulmonary embolism; FiO2, fraction of inspired oxygen; NEWS-2, New Early Warning Score; ICU, intensive care unit; HIV, human immunodeficiency virus; IVS, invasive ventilation support; SD, standard deviation.

aAdjusted regression model for age, male sex, Elixhauser score, and NEWS-2 differences by ethnic groups. Additional logistic regression models adjusted for any comorbidity, diabetes, and CKD were also carried out, but were inferior predictors compared to the selected model. COPD, cirrhotic liver disease, and HIV/AIDS were not used in logistic regression models, as they had low n values for ethnic groups.

*P < .05.